William Ciambrone's most recent trade in Sarepta Therapeutics Inc was a trade of 48,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 4, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sarepta Therapeutics Inc | William Ciambrone | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 48,000 | 48,000 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | William Ciambrone | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 8,000 | 22,099 (0%) | 0% | 0 | Common Stock | |
| Sarepta Therapeutics Inc | William Ciambrone | EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.20 per share. | 04 Mar 2022 | 1,160 | 14,099 (0%) | 0% | 79.2 | 91,872 | Common Stock |
| Sarepta Therapeutics Inc | William Ciambrone | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | William Ciambrone | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 15,000 | 15,000 (0%) | 0% | 0 | Common Stock |